These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 38477085)
1. Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer. Hu Q; Wen N; Li F; Yang D; Yue C; Wu Z; Li M; Lu H Pol J Pathol; 2023; 74(4):232-247. PubMed ID: 38477085 [TBL] [Abstract][Full Text] [Related]
2. The role of the transcription factor SIM2 in prostate cancer. Lu B; Asara JM; Sanda MG; Arredouani MS PLoS One; 2011; 6(12):e28837. PubMed ID: 22174909 [TBL] [Abstract][Full Text] [Related]
3. High Expression of CHST11 Correlates with Poor Prognosis and Tumor Immune Infiltration of Pancreatic Cancer. Zhang P; Chen D; Cui H; Luo Q Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546737 [TBL] [Abstract][Full Text] [Related]
4. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Arredouani MS; Lu B; Bhasin M; Eljanne M; Yue W; Mosquera JM; Bubley GJ; Li V; Rubin MA; Libermann TA; Sanda MG Clin Cancer Res; 2009 Sep; 15(18):5794-802. PubMed ID: 19737960 [TBL] [Abstract][Full Text] [Related]
5. The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence. Woods S; Farrall A; Procko C; Whitelaw ML Nucleic Acids Res; 2008 Jun; 36(11):3716-27. PubMed ID: 18480125 [TBL] [Abstract][Full Text] [Related]
6. Down's syndrome-associated single minded gene as a novel tumor marker. Deyoung MP; Scheurle D; Damania H; Zylberberg C; Narayanan R Anticancer Res; 2002; 22(6A):3149-57. PubMed ID: 12530058 [TBL] [Abstract][Full Text] [Related]
7. SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma. Wei Y; Zhao X; Tang H; Ma J; Wang Y; Li L Onco Targets Ther; 2024; 17():45-61. PubMed ID: 38292061 [TBL] [Abstract][Full Text] [Related]
8. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq. Zhuang H; Chen X; Wang Y; Huang S; Chen B; Zhang C; Hou B Cancer Immunol Immunother; 2022 Mar; 71(3):601-612. PubMed ID: 34279685 [TBL] [Abstract][Full Text] [Related]
9. Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies. Chatterjee A; Dutta S; Mukherjee S; Mukherjee N; Dutta A; Mukherjee A; Sinha S; Panda CK; Chaudhuri K; Roy AL; Mukhopadhyay K BMC Med Genet; 2013 Jan; 14():12. PubMed ID: 23343470 [TBL] [Abstract][Full Text] [Related]
10. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis. Wang Y; Kong Y; Yang Q; Zhong C; Zhou D Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008 [TBL] [Abstract][Full Text] [Related]
11. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma. Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253 [TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation. Qin B; Dong M; Wang Z; Wan J; Xie Y; Jiao Y; Yan D Oncol Rep; 2021 Mar; 45(3):1059-1071. PubMed ID: 33650646 [TBL] [Abstract][Full Text] [Related]
13. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s. Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743 [TBL] [Abstract][Full Text] [Related]
14. Targeting SIM2-s decreases glioma cell invasion through mesenchymal--epithelial transition. Su Y; Wang J; Zhang X; Shen J; Deng L; Liu Q; Li G J Cell Biochem; 2014 Nov; 115(11):1900-7. PubMed ID: 24909296 [TBL] [Abstract][Full Text] [Related]
15. Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. DeYoung MP; Tress M; Narayanan R Cancer Lett; 2003 Oct; 200(1):25-31. PubMed ID: 14550949 [TBL] [Abstract][Full Text] [Related]
16. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer. Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y Front Immunol; 2021; 12():758004. PubMed ID: 34887861 [TBL] [Abstract][Full Text] [Related]
17. Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications. Tamaoki M; Komatsuzaki R; Komatsu M; Minashi K; Aoyagi K; Nishimura T; Chiwaki F; Hiroki T; Daiko H; Morishita K; Sakai Y; Seno H; Chiba T; Muto M; Yoshida T; Sasaki H Cancer Sci; 2018 Apr; 109(4):1121-1134. PubMed ID: 29427302 [TBL] [Abstract][Full Text] [Related]
18. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
19. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer. Ding C; Yu Z; Li X; Zhu J; Dai M; He Q Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365 [TBL] [Abstract][Full Text] [Related]
20. Ethanol Activation of PKA Mediates Single-Minded 2 Expression in Neuronal Cells. Wang X; Yang Z; Sun Y; Zhou H; Chu G; Zhang J; Meng X Mol Neurobiol; 2015 Dec; 52(3):1234-1244. PubMed ID: 25319570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]